FYERS
Home
/
Stocks
/
Profit Loss
/
Abbott India Profit & Loss

Abbott India Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹1814 Cr₹1710 Cr₹1724 Cr₹1757 Cr₹1738 Cr₹1605 Cr₹1614 Cr₹1633 Cr₹1558 Cr₹1439 Cr₹1437 Cr₹1494 Cr₹1479 Cr₹1343 Cr₹1322 Cr₹1379 Cr₹1304 Cr₹1255 Cr₹1224 Cr₹1222 Cr₹1218 Cr₹1096 Cr₹1095 Cr₹1055 Cr₹1064 Cr₹961 Cr₹1078 Cr₹1055 Cr₹999 Cr₹906 Cr₹948 Cr₹980 Cr₹845 Cr₹788 Cr₹881 Cr₹931 Cr₹706 Cr₹715 Cr₹756 Cr₹729 Cr₹738 Cr₹690 Cr₹670 Cr₹649 Cr₹637 Cr₹601 Cr₹574 Cr₹589 Cr₹525 Cr₹494 Cr₹480 Cr₹453 Cr₹440 Cr₹420 Cr₹448 Cr₹417 Cr
₹75 Cr₹76 Cr₹70 Cr₹70 Cr₹73 Cr₹76 Cr₹72 Cr₹60 Cr₹67 Cr₹81 Cr₹56 Cr₹56 Cr₹56 Cr₹50 Cr₹44 Cr₹34 Cr₹27 Cr₹21 Cr₹19 Cr₹18 Cr₹19 Cr₹16 Cr₹15 Cr₹22 Cr₹28 Cr₹28 Cr₹28 Cr₹29 Cr₹30 Cr₹29 Cr₹38 Cr₹25 Cr₹22 Cr₹59 Cr₹19 Cr₹15 Cr₹24 Cr₹15 Cr₹14 Cr₹14 Cr₹14 Cr₹13 Cr₹12 Cr₹13 Cr₹13 Cr₹14 Cr₹12 Cr₹12 Cr₹10 Cr₹9 Cr₹19 Cr₹7 Cr₹7 Cr₹6 Cr₹6 Cr₹6 Cr
₹1889 Cr₹1785 Cr₹1794 Cr₹1827 Cr₹1811 Cr₹1681 Cr₹1686 Cr₹1693 Cr₹1625 Cr₹1520 Cr₹1493 Cr₹1550 Cr₹1535 Cr₹1393 Cr₹1366 Cr₹1413 Cr₹1331 Cr₹1276 Cr₹1243 Cr₹1240 Cr₹1237 Cr₹1112 Cr₹1110 Cr₹1077 Cr₹1092 Cr₹989 Cr₹1106 Cr₹1084 Cr₹1028 Cr₹936 Cr₹985 Cr₹1004 Cr₹867 Cr₹847 Cr₹900 Cr₹946 Cr₹731 Cr₹731 Cr₹770 Cr₹744 Cr₹752 Cr₹702 Cr₹682 Cr₹662 Cr₹650 Cr₹614 Cr₹586 Cr₹601 Cr₹535 Cr₹503 Cr₹499 Cr₹460 Cr₹447 Cr₹426 Cr₹454 Cr₹423 Cr
₹1311 Cr₹1248 Cr₹1279 Cr₹1274 Cr₹1312 Cr₹1194 Cr₹1196 Cr₹1211 Cr₹1185 Cr₹1127 Cr₹1067 Cr₹1131 Cr₹1141 Cr₹1080 Cr₹1028 Cr₹1054 Cr₹1051 Cr₹979 Cr₹972 Cr₹979 Cr₹968 Cr₹905 Cr₹868 Cr₹828 Cr₹845 Cr₹838 Cr₹854 Cr₹866 Cr₹840 Cr₹758 Cr₹805 Cr₹790 Cr₹738 Cr₹686 Cr₹722 Cr₹734 Cr₹657 Cr₹656 Cr₹637 Cr₹628 Cr₹637 Cr₹610 Cr₹574 Cr₹566 Cr₹546 Cr₹536 Cr₹491 Cr₹505 Cr₹459 Cr₹447 Cr₹420 Cr₹392 Cr₹403 Cr₹379 Cr₹380 Cr₹367 Cr
₹598 Cr₹556 Cr₹533 Cr₹572 Cr₹518 Cr₹505 Cr₹508 Cr₹499 Cr₹458 Cr₹411 Cr₹443 Cr₹436 Cr₹411 Cr₹330 Cr₹356 Cr₹377 Cr₹297 Cr₹315 Cr₹288 Cr₹278 Cr₹284 Cr₹222 Cr₹257 Cr₹263 Cr₹261 Cr₹167 Cr₹267 Cr₹233 Cr₹204 Cr₹182 Cr₹184 Cr₹219 Cr₹133 Cr₹165 Cr₹182 Cr₹216 Cr₹78 Cr₹78 Cr₹137 Cr₹120 Cr₹119 Cr₹97 Cr₹112 Cr₹100 Cr₹107 Cr₹81 Cr₹98 Cr₹100 Cr₹80 Cr₹60 Cr₹83 Cr₹72 Cr₹49 Cr₹52 Cr₹78 Cr₹61 Cr
₹6 Cr₹6 Cr₹5 Cr₹8 Cr₹6 Cr₹4 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹4 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹5 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹75 L₹43 L₹52 L₹56 L₹2 Cr₹51 L₹59 L₹51 L₹2 Cr₹1 L₹1 L₹2 L₹2 Cr₹7 L₹41 L₹3 L₹46 L₹2 L₹1 L₹1 L₹1 L₹2 L₹1 L₹3 L₹1 L₹0₹0
₹572 Cr₹531 Cr₹509 Cr₹546 Cr₹493 Cr₹483 Cr₹488 Cr₹479 Cr₹437 Cr₹390 Cr₹422 Cr₹415 Cr₹390 Cr₹308 Cr₹335 Cr₹355 Cr₹275 Cr₹292 Cr₹267 Cr₹257 Cr₹264 Cr₹202 Cr₹238 Cr₹244 Cr₹243 Cr₹149 Cr₹251 Cr₹216 Cr₹187 Cr₹177 Cr₹180 Cr₹214 Cr₹129 Cr₹159 Cr₹178 Cr₹212 Cr₹73 Cr₹72 Cr₹133 Cr₹116 Cr₹115 Cr₹91 Cr₹108 Cr₹96 Cr₹104 Cr₹78 Cr₹95 Cr₹96 Cr₹76 Cr₹56 Cr₹79 Cr₹68 Cr₹44 Cr₹47 Cr₹74 Cr₹56 Cr
₹429 Cr₹395 Cr₹376 Cr₹415 Cr₹366 Cr₹367 Cr₹361 Cr₹359 Cr₹328 Cr₹287 Cr₹311 Cr₹313 Cr₹290 Cr₹231 Cr₹247 Cr₹266 Cr₹206 Cr₹211 Cr₹199 Cr₹192 Cr₹196 Cr₹152 Cr₹177 Cr₹181 Cr₹180 Cr₹111 Cr₹187 Cr₹178 Cr₹117 Cr₹113 Cr₹117 Cr₹138 Cr₹82 Cr₹100 Cr₹115 Cr₹138 Cr₹48 Cr₹42 Cr₹86 Cr₹75 Cr₹74 Cr₹59 Cr₹68 Cr₹61 Cr₹67 Cr₹50 Cr₹65 Cr₹64 Cr₹51 Cr₹38 Cr₹53 Cr₹45 Cr₹30 Cr₹32 Cr₹50 Cr₹38 Cr

Share Price Live Stats

Open (₹)26,070.00
Volume (₹)1,636.00
High (₹)26,230.00
Upper Circuit31,280.00
Low (₹)25,910.00
Lower Circuit20,860.00
Prev Close26,070.00
52W High (₹)30,655.00
Price26,150.00
52W Low (₹)25,135.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)55393.60 Cr
Div. Yield (%)2.52
PE Ratio34.31
Debt to Equity0.00
Price to Book11.60
Book Value2,234.20
EPS (TTM)759.87
Face Value10.00
ROE (%)34.67

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
ABBOTINDIANSE
LTP
1W Low
1W High
Market cap (₹)
1753-7 (-0.40%)
1725.50
1778
4,22,427Cr
9147-193 (-2.07%)
8937.50
9431.50
2,39,982Cr
4576.2-80.7 (-1.73%)
4550.40
4682
1,75,196Cr
1130.1+12.6 (1.13%)
1107.30
1150.90
1,13,790Cr
2065.3+28.7 (1.41%)
2007.80
2086
1,09,143Cr
1324.6+23.6 (1.81%)
1300.20
1337.50
1,07,746Cr
1222.4+25.4 (2.12%)
1196.90
1250.70
1,01,894Cr
2282.3-86.2 (-3.64%)
2279.50
2426.80
97,264Cr
1670-23 (-1.36%)
1647.10
1715
96,376Cr
1962.5+6 (0.31%)
1925.70
1990.90
89,592Cr
26150+150 (0.58%)
25500
26550
55,394Cr
Empty box

No content available